-Blog Post
Pfizer Stock Is Plunging Today – What’s Going On
Pfizer Inc (NYSE: PFE) has decided to continue the clinical development of the oral late-stage glucagon-like peptide-1 receptor agonist (GLP-1-RA) candidate, danuglipron (PF-06882961), for adults with obesity and